1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI);Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Lancet,1986
2. The GUSTO Angiographic Investigators;The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction;N Engl J Med,1993
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group;Lancet,1988
4. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials;Keeley;Lancet,2003
5. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction;Morishima;J Am Coll Cardiol,2000